All News

Pharmacy schools have also been seeing a change not only in education about personalized patient care and community-centered care.

Despite the economic and structural support, rural, poor, and underserved communities still have wide disparities in health outcomes.

Our wacky health care system can’t pay pharmacies a few more dollars to survive, but we can spend billions of dollars on shipping costs.

Ongoing studies utilizing large-scale health databases that incorporate environmental, lifestyle, biological, and phenotypic data may provide insight that leads to better cancer prevention and treatment.

Tune in to this enlightening episode of Pharmacy Focus: Policy Edition to gain a deep understanding of the challenges, implications, and advocacy strategies surrounding provider status for pharmacists.

Artificial intelligence has helped ensure a data-driven methodology for evaluating eligibility criteria for clinical trials, facilitating more inclusive trial design.

October offers us a chance to take a step back to admire the hard work and dedication that pharmacists show day in and day out.

Craig Dolan, PharmD, MBA, BSPharm discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

Expert explains how the role of pharmacists in myelofibrosis treatment has evolved significantly over the past decade.

Katalin Karikó, PhD, and Drew Weissman, MD, PhD, win Nobel Prize for discoveries in the area of nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

The origins of American Pharmacists Month trace back to October 1925, when radio stations nationwide aired special programming for a week to spotlight the pharmacy profession.

The MARIPOSA study evaluated amivantamab-vmjw (Rybrevant; Janssen Pharmaceutical) in combination with lazertinib compared to osimertinib and compared to lazertinib monotherapy in the first-line treatment of EGFR-mutated non–small cell lung cancer.

The most persuasive reason for industry-academia collaboration is the many opportunities it opens for pharmacy students who may not have considered all the ways they can use their PharmD to serve the cause of humankind.

The study authors suggest that after initiating alpelisib, patients should be proactive by improving glycemic status to reduce the risk of developing hyperglycemia.

Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.

A workgroup of asthma treatment experts introduced 6 new criteria that those diagnosed with asthma must meet to be in remission.

Investigators said that these results were promising, indicating that trigonelline could help to alleviate cognitive decline associated with aging.

The FDA has issued a Prescription Drug User Fee Act fate of March 26, 2024, for sotatercept (Merck) as treatment for adults with pulmonary arterial hypertension.

Investigators also found that rates of type 1 diabetes have been on the rise since 2016.

Environmental factors may change sleep patterns over time, which subsequently affects rapid eye movement sleep.

Individuals taking HIV prevention prefer the PrEP oral daily dose compared to new treatment methods.

Pharmacists are experts at juggling shortages of all kinds, however, and L’Altrelli said they are crucial team members regarding opioid access challenges.

Lutetium Lu177 dotatate demonstrated significant and clinically meaningful progression-free survival for those with SSTR-positive and inoperable midgut neuroendocrine tumor.

The combined enfortumab vedotin-ejfv and pembrolizumab treatment is recommended for patients with locally advanced or metastatic urothelial cancer who are ineligible for cisplatin-containing therapy.

Gepirone hydrochloride ER (Exxua; Fabre-Kramer Pharmaceuticals Inc) is in a new class of antidepressants, making it the first and only approved antidepressant that selectively targets serotonin 1A receptors.

At a 6-month follow-up, supplemental creatine intervention significantly improved scores for fatigue symptoms and tissue bioenergetics related to COVID-19 infection.

In this final episode, we spoke with Claudia Fox, MD, MPH, FAAP, an associate professor of pediatrics at the University of Minnesota Medical School in Minneapolis.

Teprotumumab (Tepezza) is a promising treatment for thyroid eye disease , although its precise mechanism of action remains incompletely characterized.

Study findings showed a 10% increase in the proportion of individuals staying home due to COVID-19 policy restrictions being associated with a 0.27 increase in PHQ-9 scores for depression.

Abrocitinib can reduce allergic responses in patients with a peanut allergy by decreasing cytokine activity and maintaining regulatory T cell activation.